Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients

Journal of Investigational Allergology and Clinical Immunology

Volumn 13, Issue 1, 2003, Pages 20-25

  Martin Garcia C ^a   Hinojosa, Miguel ^a   Berges, P ^a   Camacho, E ^a   Garcia Rodriguez R ^a   Alfaya, T ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Aspirin induced asthma; Asthma; Celecoxib; COX 2 inhibitors; Cyclooxygenase enzyme

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; IBUPROFEN; INDOMETACIN; NAPROXEN; NEBUPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PYRAZOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; PREVALENCE; PROVOCATION TEST; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; SPIROMETRY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SINGLE-BLIND METHOD; SULFONAMIDES; TREATMENT OUTCOME;

EID: 0038127056     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Szczeklik, A., Stevenson, D.D. Aspirin-induced asthma. Advances in pathogenesis and management. J Allergy Clin Immunol 1999, 104:5-13.
2. Quiralte, J., Blanco, C., Castillo, R., Delgado, J., Carrillo, T. Intolerance to nonsteroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996, 98:678-685.
3. Picado, C., Castillo, J.A., Montserrat, J.M., Agust-Vidal, A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989, 2:127-129.
4. Marquette, C.H., Saulnier, F., Leroy, O., Wallaert, B., Chopin, C., Demarcq, J.M., Durocher, A., Tonnel, A.B. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near-fatal attack of asthma. Am Rev Respir Dis 1992, 146:76-81.
5. Szczeklik, A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990, 3:588-593.
6. Vane, J.R. Inhibition of prostaglandine synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971, 231:232-235.
7. Demoly, P., Jaffuel, D., Lequeux, N., Weksler, B., Creminon, C., Michel, F., Godard, P., Bousquet, J. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997, 155:670-675.
8. Hawkey, C.J. COX-2 inhibitors. Lancet 1999, 353:307-314.
9. National Institutes of Health, National Heart, Lung and Blood Institute. Global initiative for asthma: global strategy for asthma management and prevention. NHLBI/WHO workshop report, March 1993. Publ No. 95:3659, Jan 1995.
10. Nelson, H.S. Asthma Guidelines and Outcomes. In E. Middlenton, E. Ellis, J.W. Yunginger, N.F. Adkinson, W.W. Busse, Allergy, principles and practice (fifth edition). St. Louis, Missouri: Mosby-Yearbook Inc. 1998, pp. 927-937.
11. Ispano, M., Fontana, A., Scibilia, J., Ortolani, C. Oral challenge with alternative nonsteroidal antiinflammatory drug (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs 1993, 46:253-256.
12. Settipane, R.A., Schrank, P.J., Simon, R.A., Mathison, D.A., Christiansen, S., Stevenson, D.D. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995, 96:480-485.
13. Schwarz, N., Ham Pong, A. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann Allergy Asthma Immunol 1996, 77:473-474.
14. Bianco, S., Robuschi, M., Petrigni, G., Scuri, M., Pieroni, M.G., Refini, R.M., Vaghi, A., Sestini, P.S. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993, 46:115-120.
15. Kosnik, M., Music, E., Matjaz, E, Suskovic, S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998, 53:1231-1233.
16. Valero, A.L., Gonzalez Morales, M.A., Montora Lacomba, J., Malet Casajuana, A. Nimesulida como tratamiento alternativo en pacientes con intolerancia a antiinflamatorios no esesteroideos. Rev Esp Alergol Inmunol 1998, 13:336-338.
17. Bavbek, S., Celik, G., Ediger, D., Mungan, D., Demirel, Y.S., Misirligil, Z. The use of nimesulide in patients with acetylsalicylic and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999, 36:657-663.
18. Valero Santiago, A.L. Bloqueadores de receptores COX-2: Experiencia con nimesulide. Alergol Inmunol Clin 1999, 14:38-43.
19. Glaser, K., Sung, M.L., O'Neill, K., Belfast, M., Hartman, D., Carlson, R., Kreft, A., Kubrak, D., Hsiao, C.L., Weichman, B. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995, 281:107-111.
20. Hayllar, J., Bjamason, I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995, 346:1629.
21. Scott, C.J., Lamb, H.M. Rofecoxib. Drugs 1999, 58:499-505.
22. Szczeklik, A., Nizankowska, E., Bochenek, G., Nagraba, K., Mejza, F., Swierczynska, M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001, 31:219-225.
23. Clemett, D., Goa, K.L. Celecoxib: a review of its use in osteoarthritis, rheumatoid, arthritis and acute pain. Drugs 2000, 59:957-980.
24. Bensen, W.G., Fiechtner, J.J., Mc Millen, J.I., Zhao, W.W., Yu, S.S., Woods, E.M., Hubbard, R.C., Isakson, R.C., Verburg, K.M., Geis, G.S. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 1999, 74:1095-1105.
25. Simon, L.S., Weaver, A.L., Graham, D.Y., Kivit, A.J., Lipsky, P.E., Hubbard, R.C., Isakson, P.C., Verburg, K.M., Yu, S.S., Zhao, W.W., Geis, G.S. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 1999, 282:1921-1928.
26. Hubbard, R.C., Mehlisch, D.R., Jasper, D.R., Nugent, M.J., Yu, S., Isakson, P.C. SC-58635, a highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model. J Invest Med 1996, 44:293.
27. Patterson, R., Bello, A.E., Lefkowith, J. Immunologic tolerability profile of celecoxib. Clin Ther 1999, 21:2065-2079.
28. Stevenson, D.D. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984, 74:517.